| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2881732 | The Annals of Thoracic Surgery | 2009 | 7 Pages |
Abstract
Levosimendan significantly enhanced primary weaning from CPB compared with placebo in patients undergoing 3-vessel on-pump coronary artery bypass grafting. The need for additional inotropic or mechanical therapy was decreased.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Heidi I. MD, PhD, Jouko R. MD, PhD, Leo O. MD, PhD, Matti MD, PhD, Mika MD, PhD, Kari A. MD, PhD, Anne H. MD, PhD, Kari T. MD, PhD, Tarja K. MD, PhD, Toni MS, Raili T. MD, PhD, Mika MD, PhD, Markku T. MD, PhD,